COVID-19 outcome is not affected by anti-CD20 or high-titer convalescent plasma in immunosuppressed patients

Abstract The role of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) convalescent plasma in the treatment of Coronavirus Disease 2019 (COVID-19) in immunosuppressed individuals remains controversial. We describe the course of COVID-19 in patients who had received anti-CD20 therapy withi...

Description complète

Détails bibliographiques

Auteurs principaux:	Mary J. Kasten, Brian D. Lahr, Anusha Parisapogu, Zachary A. Yetmar, John C. O’Horo, Robert Orenstein, Pablo Moreno Franco, Raymund R. Razonable, Paschalis Vergidis, Aditya S. Shah, Mark J. Enzler, David J. Inwards, Philippe R. Bauer
Format:	Artigo
Langue:	Inglês
Publié:	Nature Portfolio 2023-12-01
Collection:	Scientific Reports
Accès en ligne:	https://doi.org/10.1038/s41598-023-48145-x
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!